Amgen (AMGN)
(Real Time Quote from BATS)
$337.85 USD
+0.47 (0.14%)
Updated Sep 23, 2024 09:44 AM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Brokerage Reports
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 1 - 20 ( 438 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 091624
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 91224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Key Takeaways from KOL Panels at Our Immune Cell Engager Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 2124
Provider: Stock Traders Daily
Analyst: Research Department